deltatrials
Completed PHASE2 NCT00066066

Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Conditions Periodontal Diseases Periodontitis
Interventions Amoxicillin Doxycycline Metronidazole Scaling and root planing
Updated 5 times since 2017 Last updated: Mar 6, 2013 Started: Jul 31, 2003 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This PHASE2 trial investigates Periodontal Diseases and Periodontitis and is currently completed. National Institute of Dental and Craniofacial Research (NIDCR) leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • The Forsyth Institute
Data source: The Forsyth Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Cambridge, United States